Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
December 16, 2024
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230
Feliciana Mariotti, Anna Pira, Naomi De Luca, et al.
International Journal of Molecular Sciences
|
December 22, 2019
Insight into <i>Nephrocan</i> Function in Mouse Endoderm Patterning
Martina Addeo, Silvia Buonaiuto, Ilaria Guerriero, et al.
Allergy
|
November 4, 2024
A microarray-based IgE-molecular mimicry index (IgE-MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?
Enrico Scala, Stefania Madonna, Damiano Abeni, et al.
The Journal of Dermatological Treatment
|
June 9, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Edoardo Mortato, Niccolò Gori, Giacomo Caldarola, et al.
Dermatology (Basel, Switzerland)
|
April 23, 2025
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
Niccolò Gori, Marco Galluzzo, Andrea Chiricozzi, et al.
Bone Marrow Transplantation
|
August 22, 2019
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells
Lucia Prezioso, Ilenia Manfra, Sabrina Bonomini, et al.
International Journal of Molecular Sciences
|
January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative Disorders
Luca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Frontiers in Immunology
|
April 27, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy
Martina Morelli, Giovanni Luca Scaglione, Anna Dattolo, et al.
Journal of Clinical Medicine
|
July 13, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
Marco Galluzzo, Emanuele Trovato, Marina Talamonti, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
December 16, 2024
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230
Feliciana Mariotti, Anna Pira, Naomi De Luca, et al.
International Journal of Molecular Sciences
|
December 22, 2019
Insight into <i>Nephrocan</i> Function in Mouse Endoderm Patterning
Martina Addeo, Silvia Buonaiuto, Ilaria Guerriero, et al.
Allergy
|
November 4, 2024
A microarray-based IgE-molecular mimicry index (IgE-MMI): A biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?
Enrico Scala, Stefania Madonna, Damiano Abeni, et al.
The Journal of Dermatological Treatment
|
June 9, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Edoardo Mortato, Niccolò Gori, Giacomo Caldarola, et al.
Dermatology (Basel, Switzerland)
|
April 23, 2025
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
Niccolò Gori, Marco Galluzzo, Andrea Chiricozzi, et al.
Bone Marrow Transplantation
|
August 22, 2019
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells
Lucia Prezioso, Ilenia Manfra, Sabrina Bonomini, et al.
International Journal of Molecular Sciences
|
January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative Disorders
Luca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Frontiers in Immunology
|
April 27, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy
Martina Morelli, Giovanni Luca Scaglione, Anna Dattolo, et al.
Journal of Clinical Medicine
|
July 13, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
Marco Galluzzo, Emanuele Trovato, Marina Talamonti, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 10, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Marina Talamonti, Filomena Russo, Giovanna Malara, et al.
Page
of 6